Detalhe da pesquisa
1.
Impact of early palliative care on additional line of chemotherapy in metastatic breast cancer patients: results from the randomized study OSS.
Support Care Cancer
; 31(1): 82, 2022 Dec 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36574052
2.
Does a homeopathic medicine reduce hot flushes induced by adjuvant endocrine therapy in localized breast cancer patients? A multicenter randomized placebo-controlled phase III trial.
Support Care Cancer
; 27(5): 1879-1889, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30194492
3.
Motivations of patients seeking supportive care for cancer from physicians prescribing homeopathic or conventional medicines: results of an observational cross-sectional study.
Homeopathy
; 105(4): 289-298, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27914568
4.
Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial.
Lancet Oncol
; 14(1): 72-80, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23246022
5.
Can treatment with Cocculine improve the control of chemotherapy-induced emesis in early breast cancer patients? A randomized, multi-centered, double-blind, placebo-controlled Phase III trial.
BMC Cancer
; 12: 603, 2012 Dec 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-23244208
6.
Chemotherapy for metastatic breast cancer. Comparison of clinical practice and cost of drugs in two cohorts of patients: 1994-1998 and 2003-2006.
Breast Cancer Res Treat
; 128(1): 187-95, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21184270
7.
Final results of ERASME-4: a randomized trial of first-line docetaxel plus either capecitabine or epirubicin for metastatic breast cancer.
Oncology
; 80(3-4): 262-8, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21734418
8.
Efficacy of trastuzumab in routine clinical practice and after progression for metastatic breast cancer patients: the observational Hermine study.
Oncologist
; 15(8): 799-809, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20671105
9.
A comparative study of exemestane versus anastrozole in patients with postmenopausal breast cancer with visceral metastases.
Clin Breast Cancer
; 9(1): 39-44, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19299239
10.
Bevacizumab and paclitaxel for breast cancer patients with central nervous system metastases: a case series.
Clin Breast Cancer
; 9(2): 118-21, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19433393
11.
Methotrexate for 2000 FIGO low-risk gestational trophoblastic neoplasia patients: efficacy and toxicity.
Am J Obstet Gynecol
; 200(6): 643.e1-6, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19393597
12.
Adjuvant docetaxel for node-positive breast cancer.
N Engl J Med
; 352(22): 2302-13, 2005 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-15930421
13.
[Adjuvant therapies: the example of breast cancer]. / Traitements adjuvants: l'exemple du cancer du sein.
Rev Prat
; 58(8): 817-9, 2008 Apr 30.
Artigo
em Francês
| MEDLINE | ID: mdl-18630815
14.
First epidemiological data from the French Trophoblastic Disease Reference Center.
Am J Obstet Gynecol
; 196(2): 172.e1-5, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17306669
15.
[Cervix cancer and corpus cancer of the uterus]. / Tumeurs du col utérin, tumeur du corps utérin.
Rev Prat
; 61(10): 1435-42, 2011 Dec.
Artigo
em Francês
| MEDLINE | ID: mdl-22288360
16.
Randomized parallel study of doxorubicin plus paclitaxel and doxorubicin plus cyclophosphamide as neoadjuvant treatment of patients with breast cancer.
J Clin Oncol
; 22(24): 4958-65, 2004 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15611510
17.
Disease-free survival advantage of weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients: 6-year follow-up results of the French adjuvant study group 08 trial.
J Clin Oncol
; 22(23): 4622-30, 2004 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15505276
18.
Dendritic cell infiltration and prognosis of early stage breast cancer.
Clin Cancer Res
; 10(22): 7466-74, 2004 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15569976
19.
Trebananib (AMG 386) plus weekly paclitaxel with or without bevacizumab as first-line therapy for HER2-negative locally recurrent or metastatic breast cancer: A phase 2 randomized study.
Breast
; 24(3): 182-90, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25747197
20.
A multicenter phase II study of cisplatin and docetaxel (Taxotere) in the first-line treatment of advanced ovarian cancer: a GINECO study.
Cancer Chemother Pharmacol
; 53(6): 489-95, 2004 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-14767617